Salix Pharmaceuticals (SLXP): Q2 EPS of $0.79 beats by $0.25. Revenue of $181M (+36% Y/Y)...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor
Salix Pharmaceuticals (SLXP): Q2 EPS of $0.79 beats by $0.25. Revenue of $181M (+36% Y/Y) in-line. Shares +9.4% AH. (PR)